Sharmilee Patel is an experienced professional in business development and program management within the biotechnology and pharmaceutical sectors, currently serving as Head of Business Development for Oxford Biomedica in the US since August 2021. With a strong background in cell and gene therapy manufacturing, Sharmilee has held senior roles at notable organizations, including Senior Director at Oxford Biomedica and Director of Business Development at Cytovance Biologics. Previous positions include consultancy at Avem Bio LLC and various management roles at Fujifilm Diosynth Biotechnologies and WuXi AppTec, demonstrating a deep understanding of manufacturing processes, quality control, and market strategies. Sharmilee holds a Bachelor of Science in Chemistry from the University of Alabama at Birmingham and a Master Black Belt in Lean/SixSigma from STARsixsigma.